...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZCC relationship to ZEL!
3
Apr 02, 2019 11:54AM
4
Apr 02, 2019 02:36PM

RVX/OL...I believe what you posted yesterday is the NR on this subject, correct?

"CALGARY, Aug. 2, 2016 /CNW/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") announced today that it has changed its name to Zenith Capital Corp. concurrent with the internal corporate reorganization which the Company has determined will be effective on August 1, 2016. The name change and reorganization were approved by shareholders at the annual and special meeting of shareholders held on January 7, 2016. The reorganization results in the transfer of the Company's principal operating assets to Zenith Epigenetics Ltd., a wholly-owned subsidiary of Zenith Capital Corp., in exchange for additional common shares of Zenith Epigenetics Ltd. Zenith Capital Corp. retains its investment in the royalty preferred shares of Resverlogix Corp. As Zenith Capital Corp. owns all of the securities of Zenith Epigenetics Ltd., there is no immediate change in the ultimate beneficial ownership of the operating assets."

Has there been anything released subsequently by Zenith officially that supersedes this? Just asking.

 

Koo

 

 

3
Apr 02, 2019 04:10PM
4
Apr 02, 2019 04:51PM
4
Apr 13, 2019 01:53PM
Share
New Message
Please login to post a reply